MYRIAD GENETICS INC: Vestal Point Capital, LP amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Vestal Point Capital, LP amended its Schedule 13G stake filing for Myriad Genetics Inc., disclosing a change in its passive position under SEC accession 0000902664-26-004582. The filing did not specify the size of the stake or the direction of the change. The update matters because 13G amendments signal shifts in institutional ownership that can influence governance and shareholder votes. Investors will watch for the next 13F or 13G filing to confirm whether Vestal Point increased or reduced its holding.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Myriad Genetics Inc, Vestal Point Capital, LP